THERAPEUTIC DRUG MONITORING OF MEROPENEM AND PIPERACILIN ADMINISTERED IN CONTINUOUS INFUSION. PRELIMINARY DATA

ARE EXTENDED AND CONTINUOUS INFUSIONS OF TIME DEPENDENT ANTIBIOTICS USED IN THE MANAGEMENT OF SEPSIS IN ENGLAND TODAY?

PEAKS AND TROUGHS: VARIATIONS IN THE AVAILABILITY OF THERAPEUTIC DRUG MONITORING IN CRITICAL CARE UNITS ACROSS LONDON

USE OF SYSTEMIC ANTIFUNGAL DRUGS IN CRITICALLY ILL PATIENTS. DATA FROM THE ENVIN-HELICS REGISTRY 2013-2014

USE OF BETA-LACTAMS ANTIBIOTICS IN ICU PATIENTS

VARIABILITY IN AMINOGLYCOSIDE DOSING IN INTENSIVE CARE UNITS ACROSS LONDON - SHOULD OUR METHODS BE STANDARDISED?

B-LACTAMS SERUM CONCENTRATIONS IN CRITICALLY ILL CIRRHOTIC PATIENTS: A MATCHED-CONTROL STUDY

IMPACT OF AN INDUCEMENT TO GIVE HIGH DOSES OF AMIKACIN AND GENTAMICIN ON SERUM CONCENTRATIONS IN CRITICALLY ILL PATIENTS WITH SEVERE SEPSIS

THE PHARMACOKINETICS OF TIGECYCLINE IN CRITICALLY ILL ADULT PATIENTS UNDERGOING CVVHD

A HIGH AMINOGLYCOSIDE REGIMEN ASSOCIATED WITH RENAL REPLACEMENT THERAPY FOR THE TREATMENT OF MULTI-DRUG RESISTANT PATHOGENS

DE-ESCALATION OF EMPIRIC ANTIBIOTIC THERAPY IN SEPSIS - AN INDIAN OBSERVATIONAL STUDY

USE OF DAPTOMYCIN AND VANCOMYCIN IN BLOOD STREAM INFECTIONS WITH PDR ACINETOBACTER BAUMANII